Adamis Pharmaceuticals Announces a Publication with the Human Immune Monitoring Center at Stanford Demonstrating Tempol Significantly Inhibited Multiple Cytokines from COVID-19 Patient's Cells
Stock Information for Adamis Pharmaceuticals Corporation
Loading
Please wait while we load your information from QuoteMedia.